Avrobio Inc reported $-32613000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Akebia Therapeutics AKBA:US $ -59.54M 23.49M
Alnylam Pharmaceuticals ALNY:US $ -204.51M 14.96M
Applied Genetic Technologies AGTC:US $ -17.12M 4.98M
Bluebird Bio BLUE:US $ -216.82M 24.89M
Epizyme EPZM:US $ -65.83M 1.47M
Gilead Sciences GILD:US $ 2592M 1070M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
Karyopharm Therapeutics KPTI:US $ -51812000 1.77M
Macrogenics MGNX:US $ -52.89M 12.95M
Pfizer PFE:US $ 8146M 2582M
Sangamo Biosciences SGMO:US $ -47.69M 0.52M
Sarepta Therapeutics SRPT:US $ -48.14M 33.26M
Takeda 4502:JP Y 45965M 154412M